Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Oct 16 - Oct 21
GLP-1 (glucagon-like peptide-1) receptor agonists, such as Semaglutide , are a class of medications originally developed for the treatment of type 2 diabetes but have also gained recognition for their role in weight management
Emerging data suggest that they may improve health across a range of diseases, including heart disease, addiction, some kinds of cancers, and dementia
Pregnancy, plans for pregnancy, breastfeeding, personal or family history of certain endocrine cancers, and other individual medical factors should be discussed before treatment
Marquez-Meneses JD, Olaya-Bonilla SA, Barrera-Carreo S, Tibaduiza-Arvalo LC, Forero-Crdenas S, Carrillo-Vaca L, Rojas-Rodrguez LC, Calderon-Ospina CA, Rodrguez-Quintana J (2025) GLP-1 Analogues in the Neurobiology of Addiction: Translational Insights and Therapeutic Perspectives
As the week progresses, some individuals may notice a slight increase in hunger as the medication levels begin to decrease before the next scheduled dose
.png)
